Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4915477

O=C(O)C(F)(F)F.Oc1ccc2c(c1)CCNCC2

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.59
DRD1 P21728 2/20 0.59
DRD4 P21917 2/20 0.54
DRD5 P21918 1/20 0.54
DRD3 P35462 1/20 0.54
KDM1A O60341 6/20 0.49
ESR1 P03372 4/20 0.49
ESR2 Q92731 4/20 0.49
HTR2C P28335 2/20 0.47
HTR2B P41595 2/20 0.47
HTR2A P28223 1/20 0.47
ADCY6 O43306 1/20 0.44
ADCY3 O60266 1/20 0.44
ADCY9 O60503 1/20 0.44
ADCY5 O95622 1/20 0.44
ADCY8 P40145 1/20 0.44
ADCY7 P51828 1/20 0.44
ADCY2 Q08462 1/20 0.44
ADCY1 Q08828 1/20 0.44
ADCY4 Q8NFM4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7254528 0.91 DRD2 (0.49) DRD2DRD1DRD4DRD5DRD3
SCHEMBL31317940 0.84 DRD2 (0.79) DRD2DRD1DRD4DRD5DRD3
SCHEMBL4030395 0.84 DRD2 (0.79) DRD2DRD1DRD4DRD5DRD3
Hydrochloric Acid SCHEMBL11478943 0.82 DRD2 (0.76) DRD2DRD1DRD4DRD5DRD3
Bromide SCHEMBL10703420 0.82 DRD2 (0.76) DRD2DRD1DRD4DRD5DRD3
Trifluoroacetic Acid SCHEMBL5451230 0.81 HTR2C (0.61) DRD2DRD1DRD4DRD5DRD3
Oxalic Acid SCHEMBL6952790 0.77 DRD2 (0.54) DRD2DRD1DRD4DRD5DRD3
Acetic Acid SCHEMBL1648355 0.75 PNMT (0.54) DRD2DRD1
SCHEMBL4915480 0.75 ADRA2A (0.46) DRD2DRD1ESR1ESR2HTR2C
Trifluoroacetic Acid SCHEMBL7746107 0.74 PNMT (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080009479-A1 Tetrahydrobenzazepines as Histamine H3 Receptor Ligands GLAXO GROUP LIMITED (GB) 2008-01-10 US disclosed
EP-1735299-A1 TERTRAHYDROBENZAZEPINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2006-12-27 EP disclosed
WO-2005097778-A1 TETRAHYDROBENZAZEPINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009479-A1 Tetrahydrobenzazepines as Histamine H3 Receptor Ligands HRH3, HRH4, HRH1 DRD2 93/4885DRD1 263/4885DRD4 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.